nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer
|
Gillenwater, Heidi H. |
|
2005 |
47 |
3 |
p. 413-419 7 p. |
artikel |
2 |
A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, Yuh-Min |
|
2005 |
47 |
3 |
p. 373-380 8 p. |
artikel |
3 |
A report from the Society for Women's Health Research
|
Resnick, Eileen M. |
|
2005 |
47 |
3 |
p. 427-433 7 p. |
artikel |
4 |
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer
|
Alam, Naveed |
|
2005 |
47 |
3 |
p. 385-394 10 p. |
artikel |
5 |
Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer
|
Vergnenègre, A. |
|
2005 |
47 |
3 |
p. 395-404 10 p. |
artikel |
6 |
Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients
|
Prado-Garcia, Heriberto |
|
2005 |
47 |
3 |
p. 361-371 11 p. |
artikel |
7 |
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features
|
Erman, Mustafa |
|
2005 |
47 |
3 |
p. 315-323 9 p. |
artikel |
8 |
Familial multiple primary lung cancers: a population-based analysis from Sweden
|
Li, Xinjun |
|
2005 |
47 |
3 |
p. 301-307 7 p. |
artikel |
9 |
First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule
|
Quoix, Elisabeth |
|
2005 |
47 |
3 |
p. 405-412 8 p. |
artikel |
10 |
Is there a relationship between c-erbB-1 and c-erbB-2 amplification and protein overexpression in NSCLC?
|
Meert, Anne-Pascale |
|
2005 |
47 |
3 |
p. 325-336 12 p. |
artikel |
11 |
[No title]
|
Wright, Gavin |
|
2005 |
47 |
3 |
p. 425-426 2 p. |
artikel |
12 |
NSCLC—platinum or not
|
Androulakis, Nikos |
|
2005 |
47 |
3 |
p. 381-383 3 p. |
artikel |
13 |
pre v: Contents
|
|
|
2005 |
47 |
3 |
p. v- 1 p. |
artikel |
14 |
pre vi : Contents continued
|
|
|
2005 |
47 |
3 |
p. vi- 1 p. |
artikel |
15 |
pre vii: Calendar of Events
|
|
|
2005 |
47 |
3 |
p. vii- 1 p. |
artikel |
16 |
Prognostic value of smoking status in operated non-small cell lung cancer
|
Sardari Nia, Peyman |
|
2005 |
47 |
3 |
p. 351-359 9 p. |
artikel |
17 |
Psychosocial aspects of lung cancer
|
Carlsen, Kathrine |
|
2005 |
47 |
3 |
p. 293-300 8 p. |
artikel |
18 |
RETRACTED: Aberrant methylation of Reprimo in lung cancer
|
Suzuki, Makoto |
|
2005 |
47 |
3 |
p. 309-314 6 p. |
artikel |
19 |
Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases
|
Rossi, Antonio |
|
2005 |
47 |
3 |
p. 421-423 3 p. |
artikel |
20 |
The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC)
|
Yannelli, John R. |
|
2005 |
47 |
3 |
p. 337-350 14 p. |
artikel |